I am here today to apologize for a huge mistake I made during the first half of the season in 2009. I am not here to make excuses. There are none. I am not here to ask for sympathy. That would be asking too much.
I fully understand that I disappointed a lot of people–my family, my players, coaches, as well as the team’s leadership, especially Nolan Ryan and Jon Daniels, as well as young people who may have looked up to me. I am truly sorry for my careless, dangerous, and frankly, stupid, behavior last year. Clearly, you have never seen me speak from a script before. But this is a time that I need to get the words exactly right.
Here’s the biggest question: how and why did this happen? That’s a question I have had to face in numerous sessions with counselors. I’ve learned a lot about myself personally, and I recognize that this episode was an attempt to dodge personal anxieties and personal issues I needed to confront. That was the wrong way to do it. It was self-serving, and believe me, not worth it.
I know you will ask, and so here’s the answer: this was the one and only time I used this drug. I made a huge mistake, and it almost caused me to lose everything I have worked for all of my life. Shortly after I did this, MLB notified me that I would have a routine drug test. Before even taking the test, I notified the league about the drug use. Right after that test, I told Jon Daniels and Nolan Ryan about my shameful behavior. I offered them my resignation.
They asked a lot of difficult questions. Remarkably, these two men, after a lot of thought and prayer, allowed me to stay here through last season. However, they also directed me to immediately begin MLB’s drug treatment program, which is a thorough and exhaustive process, and it includes the administration of drug tests at least three times a week. I am proud to report to you that I have completed that program. I am not proud to admit this terrible error.
This morning, I talked to our players. I assured them that this will never happen again, and I asked them to forgive me. In the true spirit of a “team,” they seemed to embrace me not only as a manager but as a human being. I won’t let you down again. Please know that I will personally take on the challenge of telling young people my story and my mistake. I don’t know what form that will take, but I am committed to do that.
I am hopeful that our fans, both Rangers fans and Major League Baseball fans, will accept this heartfelt and humble attempt to say: I’m so sorry for what I did.
According to Jorge Castillo of the Washington Post, Nationals infielder Danny Espinosa declined to attend the team’s annual Winterfest because of his dissatisfaction with management following their trade for outfielder Adam Eaton.
A source told Castillo that Espinosa’s unhappiness stemmed from a belief that the acquisition would jeopardize his starting role in 2017. With Eaton in center field, Trea Turner will likely return to his post at shortstop, leaving Espinosa out in the cold — or, as the case may be, on the bench. The move shouldn’t come as a big surprise to Espinosa, however, as Nationals’ GM Mike Rizzo spoke to the possibility of trading the infielder or reassigning him to a utility role back in early November.
Offensively, the 29-year-old had a down year in 2016, slashing just .209/.306/.378 with 24 home runs in 601 PA. Defensively, he still profiles among the top shortstops in the National League, with eight DRS (Defensive Runs Saved) and 8.3 Def (Defensive Runs Above Average) in his seventh year with the club.
Espinosa will reach free agency after the 2017 season.
The Red Sox might be trying to move the wrong pitcher, according to the Boston Globe’s Nick Cafardo. Cafardo revealed that while the Sox have been trying to market right-hander Clay Buchholz, more teams would be interested in trades involving southpaw Drew Pomeranz.
The club appears reluctant to deal Pomeranz, especially because his price tag comes in at a cool $4.7 million to Buchholz’s $13.5 million in 2017. Those who have already expressed interest in the veteran hurlers, including the Twins, Mariners and Royals, also seem put off by Buchholz’s salary requirements as he enters his 32nd year.
Health could be another factor preventing teams from jumping to make trade offers, as Cafardo quotes an AL executive who believes the “medicals on both Pomeranz and Buchholz probably aren’t that great.” Neither pitcher suffered any major injuries during the 2016 season, though Pomeranz missed just over a week of play due to forearm soreness.
Pomeranz outperformed his fellow starter in 2016, pitching to a 3.32 ERA and career-best 9.8 K/9 through 170 2/3 innings with the Padres and Red Sox. He got off to an exceptionally strong start in San Diego, where his ERA dropped to 2.47 through the first half of the year before the Padres dealt him to Boston for minor league right-hander Anderson Espinoza. Buchholz, on the other hand, struggled with a 4.78 ERA and saw a decline in both his BB/9 and K/9 rates as he worked out a career-low 1.69 K/BB through 139 1/3 innings with the Sox.